ATEM Capital
ATEM Capital is a venture capital firm based in France, investing in Healthcare & Life Sciences, Industry & Hardware and Biotechnology, 11 tracked investments.
About ATEM Capital
Operating out of France, ATEM Capital is a venture capital firm. Our dataset covers 11 investments involving ATEM Capital.
Recorded deals span Healthcare & Life Sciences, Industry & Hardware, Biotechnology and Biotech. Coverage extends to 8 sectors in total. Participation spans Series A and Series B rounds.
ATEM Capital invests in innovations across the Life Sciences industry, focusing on breakthrough technologies with unmet clinical need and strong IP protection. They invest in early-stage science, next-generation biopharma companies, and post-revenue medicine automation companies, primarily in US and Western Europe markets.
Investment Focus
Investment Thesis
ATEM Capital invests in innovations across the Life Sciences industry, focusing on breakthrough technologies with unmet clinical need and strong IP protection. They invest in early-stage science, next-generation biopharma companies, and post-revenue medicine automation companies, primarily in US and Western Europe markets.
ATEM Capital Portfolio Companies
10 tracked holdings.
Team
Managing Partner at ATEM Capital. Five portfolio companies went public on NASDAQ including Atea Pharmaceuticals and Syndax Pharmaceuticals. Four portfolio companies acquired including Tobira Therapeutics for $1.7B and Amolyt Pharmaceuticals…
Managing Partner at ATEM Capital with over ten years of venture capital and private equity experience. Partner at investment firm managing US$0.75B partnership. Board member of Syndax Pharmaceuticals.
Medical Advisor at ATEM Capital and Chief Medical Director at NovaMedica. Over 15 years in clinical trials, drug development, and investments. Former practicing neurosurgeon and cardiothoracic surgeon.
Principal at ATEM Capital with over 5 years in finance and investment. Created executive summaries on 50+ life sciences companies and participated in due diligence for $30M in investment deals.
30 years of global biopharmaceutical experience with extensive oncology drug development expertise. Head of Medical Affairs at ADC Therapeutics. Former SVP at Celgene Global Health.
Explore ATEM Capital's full profile on Brouky
Portfolio companies, co-investors, AI match scores, and deal flow signals.
Other Investors in France
AstoryaVC
Finance & Blockchain, Software & Developer Tools, Healthcare & Life Sciences
Astorg
Software & Developer Tools, Healthcare & Life Sciences, Consumer, Lifestyle & Services
Asterion Ventures
Software & Developer Tools, Energy, Environment & Mobility, Industry & Hardware
Asterion
Software & Developer Tools, Energy, Environment & Mobility, Commerce & Marketing
Atlantique Business Angel Booster
Commerce & Marketing, Software & Developer Tools, E-commerce & Retail
Atlantique Vendée Innovation
Software & Developer Tools, Consumer Hardware, Developer Tools
Atria Capital
Software & Developer Tools, home improvement, manufacturing
Attollo S.A.
Software & Developer Tools, Pet Care, Vegan Products
Other Investors in Healthcare & Life Sciences / Industry & Hardware
Y Combinator
Software & Developer Tools, Finance & Blockchain, Healthcare & Life Sciences
Bessemer Venture Partners
Software & Developer Tools, Healthcare & Life Sciences, Finance & Blockchain
General Catalyst
Software & Developer Tools, Healthcare & Life Sciences, Consumer, Lifestyle & Services
Bpifrance
Software & Developer Tools, Healthcare & Life Sciences, Energy, Environment & Mobility
High-Tech Gründerfonds
Software & Developer Tools, Healthcare & Life Sciences, Industry & Hardware
SFC Capital
Software & Developer Tools, Consumer, Lifestyle & Services, Healthcare & Life Sciences
Khosla Ventures
Software & Developer Tools, Healthcare & Life Sciences, Industry & Hardware
EQT Ventures
Software & Developer Tools, Healthcare & Life Sciences, Industry & Hardware